title: Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.
authors.forename: N
authors.initials: N
authors.lastname: Quillinan
authors.forename: G
authors.initials: G
authors.lastname: Mannion
authors.forename: A
authors.initials: A
authors.lastname: Mohammad
authors.forename: R
authors.initials: R
authors.lastname: Coughlan
authors.forename: L J
authors.initials: LJ
authors.lastname: Dickie
authors.forename: M F
authors.initials: MF
authors.lastname: McDermott
authors.forename: D
authors.initials: D
authors.lastname: McGonagle
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000068800:Etanercept; D005260:Female; D005334:Fever; D056660:Hereditary Autoinflammatory Diseases / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics*; D017211:Treatment Failure; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D053590:Interleukin 1 Receptor Antagonist Protein; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; C506235:TNFRSF1A protein, human; D000068800:Etanercept